Health
DLnano-vaccines may be a promising strategy for cancer immunotherapy – News-Medical.Net
Researchers designed DLnano-vaccines displaying 60 copies of protein parts derived from the melanoma-specific antigens Trp2 and Gp100 and tested these in mouse models of melanoma, observing prolonged survival that depended on CD8 T cell activation both in the…
Reviewed by Emily Henderson, B.Sc.Sep 10 2020
Researchers designed DLnano-vaccines displaying 60 copies of protein parts derived from the melanoma-specific antigens Trp2 and Gp100 and tested these in mouse models of melanoma, observing prolonged survival that depended on CD8 T cell activation both in therapeutic and prophylactic settings.
One of the advantages of synthetic DNA technologies over other methods is the versatility of the platforms. DLnano-vaccines may be designed for various cance…
-
General22 hours agoRussia launches hundreds of drones and missiles against Ukraine in fresh attack
-
Business14 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business17 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
Business13 hours agoHere’s what analysts expect for the BHP share price in the coming year